Alcresta
Newton
About Alcresta
Alcresta is developing and commercializing innovative, point-of-care, enzyme-based nutritional products that support improved nutrition and manage disease for infants, aging adults and people battling acute conditions or chronic diseases. Alcresta’s research-based approach is innovative, proprietary and driven by the unmet nutritional needs of those people with compromised health. Alcresta’s core capabilities include expertise in adult and pediatric nutrition, as well as protein manufacturing expertise and regulatory experience that support the development and commercialization of its programs. The company’s platform is supported by the Alcresta team’s proven success in developing protein therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $139.4M
- Funding stage: M&A
- Last round: Series Unknown (Feb 2020)
- Website: alcresta.com
- Phone: 617-916-1207
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/alcresta-46404 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.